ALIKO Scientific Settles Dispute, US Subsidiary to Receive $2 Million

Paris, France – ALIKO Scientific announced a significant development involving its US subsidiary. The company has reached a settlement resolving a prior dispute, resulting in a payment of $2 million to its US subsidiary. As a consequence, related legal proceedings have been dismissed.

ALIKO Scientific, listed on Euronext Growth Paris, is known for its efforts in advancing oncology diagnostics through its international operations. This settlement reflects the company's continued commitment to navigating legal challenges effectively in support of its strategic objectives.

While the specific details of the dispute remain undisclosed, the resolution marks a positive step for ALIKO Scientific's US subsidiary, potentially enhancing its financial position and allowing the company to focus on its core activities and growth strategies in the life sciences sector.